High Frequency Oscillatory Ventilation Versus High Frequency Jet Ventilation for Congenital Diaphragmatic Hernia
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University of Utah
- Study ID
- NCT04774848
- Status
- Recruiting
Conditions
- Congenital Diaphragmatic Hernia
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 24 Hours
- Healthy Volunteers
- Not accepted
Interventions
- High Frequency Jet Ventilator — DEVICEHFJV provides short bursts of gas into the respiratory circuit at a rate of 240 to 600/min (4 to 11 Hz) and expiration is passive. It is used in conjunction with a conventional ventilator which provides positive end expiratory pressure (PEEP) and can also provide occasional sigh breaths.
- High Frequency Oscillatory Ventilator — DEVICEHFOV uses a piston diaphragm to generate alternating positive and negative pressure changes to give breaths of 300 to 900/min (5-15 Hz) given over a set mean airway pressure. Both inhalation and exhalation are active.
Study Details
The purpose of this study is to conduct a prospective study of all congenital diaphragmatic hernia (CDH) neonates managed at the University of Utah newborn intensive care unit (NICU) and Primary Children's Hospital NICU that required mechanical ventilation at birth. As both high frequency jet ventilation (HFJV) and high frequency oscillatory ventilation (HFOV) are standard approaches to ventilatory support of all neonates including CDH, CDH infants will be randomized at the time of birth or admission to either HFJV or HFOV as initial ventilator mode, stratified by position of the liver in the abdomen or thorax (if known) by 24 hours of age. Measures of oxygenation, ventilation and hemodynamics of the CDH cohort managed on HFOV compared to those on HFJV.
Key Dates
- Start date
- Dec 30, 2020
- Status verified
- Jan 2025
- Primary completion
- Jun 30, 2025
- Completion
- Aug 28, 2025
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: High Frequency Jet Ventilation (HFJV) with intrathoracic liverBabies known to have the presence of the liver in the intrathoracic space will be placed on the HFJV at delivery or as soon as possible after consent. During analysis, these babies will be compared to babies with intrathoracic liver and randomized to high frequency oscillating ventilator.
- Active Comparator: High Frequency Jet Ventilation (HFJV) without intrathoracic liverBabies who do not have any liver in the intrathoracic space will be placed on the HFJV at delivery or as soon as possible after consent. During analysis, these babies will be compared to babies without intrathoracic liver and randomized to high frequency oscillating ventilator.
- Active Comparator: High Frequency Oscillatory Ventilation (HFOV) with intrathoracic liverBabies known to have the presence of the liver in the intrathoracic space will be placed on the HFOV at delivery or as soon as possible after consent. During analysis, these babies will be compared to babies with intrathoracic liver and randomized to HFJV.
- Active Comparator: High Frequency Oscillatory Ventilation (HFOV) without intrathoracic liverBabies who do not have any liver in the intrathoracic space will be placed on the HFOV at delivery or as soon as possible after consent. During analysis, these babies will be compared to babies without intrathoracic liver and randomized to HFJV.
Primary Outcome Measure
Oxygenation Index (OI) at 24 hours of age [ Time Frame: 24 hours of age ]
Central Contacts
- Michelle Yang, MD801-581-7052
- Carrie Rau801-213-3360
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Primary Children's Hospital | Salt Lake City | Utah | 84113 | Michelle Yang, MD (PRINCIPAL_INVESTIGATOR) |
| University Hospital | Salt Lake City | Utah | 84132 | Michelle Yang, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Salt Lake City, UT
Related Studies
- A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)PHASE2 · Recruiting · University of Utah · Salt Lake City, Utah
- De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic HerniaPHASE4 · Recruiting · The University of Texas Health Science Center, Houston · Birmingham, Alabama
- Diaphragmatic Hernia Research & Exploration, Advancing Molecular ScienceRecruiting · Columbia University · Chicago, Illinois
- Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic HerniaRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio